share_log

Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Consensus Rating of "Moderate Buy" From Brokerages

Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Consensus Rating of "Moderate Buy" From Brokerages

直覺手術公司(NASDAQ:ISRG)從經紀公司獲得「中等買入」的共識評級
Defense World ·  2023/02/02 16:51

Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) has received a consensus recommendation of "Moderate Buy" from the twenty-two analysts that are presently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $276.53.

據MarketBeat Ratings報道,納斯達克(代碼:ISRG-GET Rating)已收到目前追蹤該公司的22位分析師一致提出的“適度買入”的建議。4名分析師對該股的評級為持有,13名分析師對該公司的評級為買入。過去一年對該股進行評級的分析師的平均12個月目標價為276.53美元。

ISRG has been the subject of a number of recent research reports. Piper Sandler boosted their price objective on Intuitive Surgical from $260.00 to $265.00 and gave the company an "overweight" rating in a research note on Wednesday, October 19th. Barclays boosted their price target on Intuitive Surgical from $235.00 to $298.00 in a report on Wednesday, January 4th. StockNews.com assumed coverage on Intuitive Surgical in a report on Wednesday, October 12th. They issued a "hold" rating on the stock. Morgan Stanley decreased their price objective on Intuitive Surgical from $290.00 to $265.00 and set an "equal weight" rating on the stock in a report on Wednesday, January 25th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on Intuitive Surgical from $230.00 to $245.00 in a report on Wednesday, January 25th.

ISRG是最近一些研究報告的主題。派珀·桑德勒將直覺外科公司的目標股價從260.00美元上調至265.00美元,並在10月19日(週三)的一份研究報告中給予該公司“增持”評級。巴克萊在1月4日週三的一份報告中將直覺外科公司的目標價從235.00美元上調至298.00美元。斯托克新聞網在10月12日星期三的一篇報道中報道了直覺外科公司。他們對該股的評級為“持有”。摩根士丹利在1月25日週三的一份報告中將直覺外科公司的目標價從290.00美元下調至265.00美元,並對該股設定了“同等權重”的評級。最後,德意志銀行在1月25日週三的一份報告中將直覺外科公司的目標價從230.00美元上調至245.00美元。

Get
到達
Intuitive Surgical
直覺外科公司
alerts:
警報:

Intuitive Surgical Stock Performance

直覺外科公司股票表現

NASDAQ ISRG opened at $251.19 on Thursday. Intuitive Surgical has a one year low of $180.07 and a one year high of $308.97. The stock has a 50-day moving average of $263.32 and a 200 day moving average of $235.62. The company has a market capitalization of $88.77 billion, a price-to-earnings ratio of 68.63, a PEG ratio of 4.80 and a beta of 1.36.

納斯達克週四開盤價為251.19美元。直覺外科公司的一年低點為180.07美元,一年高位為308.97美元。該股的50日移動均線切入位在263.32美元,200日移動均線切入位在235.62美元。該公司市值887.7億美元,市盈率為68.63倍,聚乙二醇率為4.80倍,貝塔係數為1.36。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its quarterly earnings data on Tuesday, January 24th. The medical equipment provider reported $1.23 EPS for the quarter, missing the consensus estimate of $1.25 by ($0.02). The business had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.66 billion. Intuitive Surgical had a return on equity of 11.27% and a net margin of 21.25%. Intuitive Surgical's quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.30 earnings per share. On average, equities analysts predict that Intuitive Surgical will post 4.22 earnings per share for the current fiscal year.
直覺外科公司(納斯達克代碼:ISRG-GET Rating)最近一次發佈季度收益數據是在1月24日(星期二)。這家醫療設備提供商公佈本季度每股收益為1.23美元,低於普遍預期的1.25美元(0.02美元)。該業務本季度營收為16.6億美元,而市場普遍預期為16.6億美元。直覺外科公司的股本回報率為11.27%,淨利潤率為21.25%。與去年同期相比,直覺外科公司的季度營收增長了6.7%。在去年同一季度,該業務公佈的每股收益為1.30美元。股票分析師平均預測,直覺外科公司本財年每股收益將達到4.22歐元。

Insider Buying and Selling

內幕買賣

In other Intuitive Surgical news, EVP Robert Desantis sold 1,629 shares of the firm's stock in a transaction that occurred on Friday, January 27th. The stock was sold at an average price of $250.00, for a total value of $407,250.00. Following the sale, the executive vice president now directly owns 6,769 shares of the company's stock, valued at $1,692,250. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, Director Amal M. Johnson sold 6,375 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, November 8th. The stock was sold at an average price of $239.36, for a total transaction of $1,525,920.00. Following the transaction, the director now owns 11,224 shares in the company, valued at $2,686,576.64. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 1,629 shares of Intuitive Surgical stock in a transaction that occurred on Friday, January 27th. The stock was sold at an average price of $250.00, for a total value of $407,250.00. Following the transaction, the executive vice president now owns 6,769 shares in the company, valued at approximately $1,692,250. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.

在直覺外科公司的另一則消息中,執行副總裁羅伯特·德桑蒂斯在1月27日(星期五)的一筆交易中出售了1,629股該公司的股票。這隻股票的平均售價為250.00美元,總價值為407,250.00美元。出售股份後,執行副總裁總裁現在直接持有該公司6769股股票,價值169.22萬美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可以通過美國證券交易委員會網站。在相關新聞中,董事在11月8日星期二的一筆交易中出售了6,375股直覺外科公司的股票。股票以239.36美元的平均價格出售,總成交金額為1,525,920.00美元。交易完成後,董事現在擁有該公司11,224股,價值2,686,576.64美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過這個環節。此外,執行副總裁羅伯特·德桑蒂斯在1月27日星期五的一筆交易中出售了1,629股直覺外科公司的股票。這隻股票的平均售價為250.00美元,總價值為407,250.00美元。交易完成後,執行副總裁總裁現在擁有該公司6769股股份,價值約1692,250美元。關於這次銷售的披露可以找到這裏。0.90%的股份由企業內部人士持有。

Hedge Funds Weigh In On Intuitive Surgical

對衝基金看好直覺外科公司

A number of institutional investors have recently added to or reduced their stakes in ISRG. Vanguard Group Inc. grew its stake in shares of Intuitive Surgical by 1.0% in the third quarter. Vanguard Group Inc. now owns 29,283,566 shares of the medical equipment provider's stock valued at $5,488,912,000 after buying an additional 282,881 shares in the last quarter. BlackRock Inc. boosted its position in shares of Intuitive Surgical by 5.6% during the 3rd quarter. BlackRock Inc. now owns 27,887,777 shares of the medical equipment provider's stock worth $5,227,284,000 after acquiring an additional 1,477,885 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Intuitive Surgical by 3.3% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 25,692,735 shares of the medical equipment provider's stock worth $5,156,788,000 after acquiring an additional 816,066 shares in the last quarter. State Street Corp boosted its position in shares of Intuitive Surgical by 0.3% during the 2nd quarter. State Street Corp now owns 15,220,507 shares of the medical equipment provider's stock worth $3,054,908,000 after acquiring an additional 38,293 shares in the last quarter. Finally, Baillie Gifford & Co. boosted its position in shares of Intuitive Surgical by 1.7% during the 4th quarter. Baillie Gifford & Co. now owns 4,268,859 shares of the medical equipment provider's stock worth $1,132,742,000 after acquiring an additional 69,717 shares in the last quarter. Hedge funds and other institutional investors own 81.96% of the company's stock.

一些機構投資者最近增持或減持了ISRG的股份。先鋒集團第三季度增持直覺外科公司股份1.0%。先鋒集團現在擁有29,283,566股這家醫療設備供應商的股票,價值5,488,912,000美元,上個季度又購買了282,881股。貝萊德股份有限公司在第三季度將其持有的直覺外科公司股票頭寸提高了5.6%。貝萊德股份有限公司現在持有這家醫療設備供應商27,887,777股股票,價值5,227,284,000美元,上個季度又購入了1,477,885股。Price T Rowe Associates Inc.MD在第二季度將其持有的直覺外科公司股票頭寸增加了3.3%。Price T Rowe Associates Inc.MD現在擁有這家醫療設備提供商25,692,735股股票,價值5,156,788,000美元,上個季度又收購了816,066股。道富銀行在第二季度將其持有的直覺外科公司股票頭寸提高了0.3%。道富集團目前持有這家醫療設備提供商15,220,507股股票,價值3,054,908,000美元,此前該公司在上個季度額外收購了38,293股。最後,Baillie Gifford&Co.在第四季度將其持有的直覺外科公司股票頭寸提高了1.7%。貝利·吉福德公司(Baillie Gifford&Co.)在上個季度增持了69,717股後,現在持有這家醫療設備供應商價值1,132,742,000美元的股票4,268,859股。對衝基金和其他機構投資者持有該公司81.96%的股票。

About Intuitive Surgical

關於直覺外科公司

(Get Rating)

(獲取評級)

Intuitive Surgical, Inc engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

直覺外科公司公司從事達芬奇外科系統及相關侵入性手術器械和附件的開發、製造和營銷。它的產品包括達芬奇和Ion。該公司由弗雷德裏克·H·莫爾、約翰·戈登·弗洛因德和羅伯特·G·楊格於1995年11月創立,總部位於加利福尼亞州桑尼維爾。

Read More

閲讀更多內容

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • Bed Bath & Beyond Is Circling the Drain
  • Allegro Microsystems Is A Well-Positioned Semiconductor Stock
  • Scotts Miracle-Gro Hits Bottom, Reversal In Play
  • Altria is a Great Recession Stock, Long-Term Outlook Uncertain
  • Novavax Shares Jumped in January While Others Slipped
  • 免費獲取斯托克新聞網關於直覺外科公司的研究報告
  • Bed Bath&Beyond正在繞着排水溝走
  • Allegro MicroSystems是一隻定位良好的半導體股票
  • 斯科特奇蹟-Gro觸底,比賽逆轉
  • 奧馳亞是一隻大衰退的股票,長期前景不確定
  • Novavax的股價在1月份大幅上漲,而其他股票則出現下滑

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接受《直覺外科公司日報》的新聞和評級-在下面輸入您的電子郵件地址,即可通過MarketBeat.com的免費每日電子郵件時事通訊接收對直覺外科公司及相關公司的最新新聞和分析師評級的每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論